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PI3Kg activity in leukocytes promotes adipose
tissue inflammation and early-onset insulin resistance
during obesity
Ludovic Breasson,1*† Barbara Becattini,1*† Claudia Sardi,† Angela Molinaro,† Fabio Zani,1‡
Romina Marone,2 Fabrizio Botindari,2 Mélanie Bousquenaud,1 Curzio Ruegg,1
Matthias P. Wymann,2§ Giovanni Solinas1†§
The phosphoinositide 3-kinase g (PI3Kg) plays a major role in leukocyte recruitment during acute inflammation and
has been proposed to inhibit classical macrophage activation by driving immunosuppressive gene expression.
PI3Kg plays an important role in diet-induced obesity and insulin resistance. In seeking to determine the underlying
molecular mechanisms, we showed that PI3Kg action in high-fat diet–induced inflammation and insulin resistance
depended largely on its role in the control of adiposity, which was due to PI3Kg activity in a nonhematopoietic cell
type. However, PI3Kg activity in leukocytes was required for efficient neutrophil recruitment to adipose tissue. Neu-
trophil recruitment was correlated with proinflammatory gene expression in macrophages in adipose tissue, which
triggered insulin resistance early during the development of obesity. Our data challenge the concept that PI3Kg is a
general suppressor of classical macrophage activation and indicate that PI3Kg controls macrophage gene expres-
sion by non–cell-autonomous mechanisms, the outcome of which is context-dependent.
INTRODUCTION
Obesity is amajormetabolic derangement that affectsmillions of people
and is a causal factor for several debilitating diseases including type 2
diabetes, cardiovascular diseases, and several types of cancer. Although
the mechanisms linking obesity to its associated diseases are still largely
unresolved, saturation of adipocyte lipid storage capacity, ectopic lipid
deposition, and metabolic inflammation is a concomitant event and
hallmark of obesity-associated diseases (1–4). Furthermore, increasing
evidence indicates that obesity causes alterations of gut microbiota
leading to a low-grade metabolic endotoxemia, which may further pro-
mote obesity-associated inflammation through Toll-like receptor 4
signaling (5, 6). Thus, signal transducers operating at the interface be-
tween innate immunity and metabolic homeostasis may play a pivotal
role in promoting obesity-associated diseases. The phosphoinositide
3-kinase g (PI3Kg) is a potent signal transducer, which is activated by
several signals implicated in innate immunity, including chemokines
and bacterial lipopolysaccharides (LPS) (7–11). PI3Kg has been re-
ported to be a key inhibitor of classical activation of macrophages
and a promoter of immunosuppressive gene expression in these cells
that enable cancer cells to evade the immune system (12–15). PI3Kg
is also activated by adrenergic signaling (16, 17), which plays a potent
role in several metabolic processes including lipolysis and adaptive
thermogenesis. Studies from our laboratory and from our colleagues
indicate that PI3Kg plays a central role in the progression of diet-induced
obesity, metabolic inflammation, and insulin resistance (18, 19). Further-
more, pharmacological inhibition of PI3Kg is a promising strategy for the
treatment of obesity-related diseases (20, 21). Two distinct mechanisms
have been put forward to explain the action of PI3Kg in diet-induced
obesity and insulin resistance. One mechanism proposes that PI3Kg
in myeloid cells promotes obesity-driven metabolic inflammation,
leading to insulin resistance and altered hepatic expression of genes
involved in lipid handling andmetabolism, thereby promoting fatty liv-
er (19). The second mechanism emphasizes the role of PI3Kg as an in-
hibitor of hormone-sensitive lipase (HSL) activation and of adaptive
thermogenesis (18). According to the latter model, PI3Kg activity with-
in a nonhematopoietic cell type promotes excessive adiposity and, con-
sequently, steatosis, metabolic inflammation, and insulin resistance
(18). However, current evidence does not establish a cause-and-effect
relationship between the involvement of PI3Kg in adiposity and meta-
bolic inflammation. Hence, the mechanism of action of PI3Kg in diet-
induced obesity and insulin resistance is still largely unresolved. Here,
we investigated the key elements of the two mechanisms described
above in mice with systemic ablation of PI3Kg in models of dietary
and genetic obesity, in mice with tissue-specific inactivation of PI3Kg,
and in cultured myeloid cells lacking PI3Kg. Our results clarify the role
of PI3Kg in diet-induced inflammation and insulin resistance and chal-
lenge the concept that PI3Kg is a general inhibitor of classical macro-
phage activation.
RESULTS
Systemic PI3Kg ablation protects mice from obesity,
inflammation, and insulin resistance caused by high-fat
diet feeding
To establish the hierarchical importance of the twomodels proposed for
PI3Kg action in obesity and insulin resistance (18, 19), it was necessary
to recapitulate the essential elements of thesemodels in the same cohort
ofmice. Thus, we first investigated these elements inmicewith systemic
ablation of PI3Kg (PI3Kg−/−) and diet-induced obesity. Compared to
control mice, PI3Kg−/− mice were protected from diet-induced obesity
(fig. S1A), insulin resistance (fig. S1, B and C), and hepatic steatosis
(fig. S1D). In parallel, hepatic expression of genes implicated in lipid
handling and metabolism was reduced (fig. S1E). Phosphorylation of
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HSL at the protein kinase A (PKA) sites Ser563 and Ser660, but not at the
AMP-activatedproteinkinase (AMPK)site Ser565,was increased inadipose
tissue from PI3Kg−/− mice (fig. S1, F and G), indicating increased PKA-
driven lipolysis in these mice. Furthermore, PI3Kg−/−mice were protected
from metabolic inflammation, as showed by decreased expression of in-
flammatorymarkers in liver (fig. S2A) and reducedmacrophage accumu-
lation in white adipose tissue (fig. S2, B and C). In addition, the adipose
tissue ofPI3Kg−/−mice showed reduced expressionofmarkers for classical
M1macrophage activation and increased expression of the gene encoding
matrix metalloproteinase 9 (MMP-9), a tissue remodeling protein and a
marker for alternative M2 macrophage activation (fig. S2D) (22, 23).
Systemic PI3Kg ablation partially protects ob/ob mice from
inflammation and insulin resistance but not obesity
PI3Kg ablation in the ob/ob backgroundprotects from insulin resistance
and metabolic inflammation indepen-
dently from differences in adiposity (19).
To test whether PI3Kg action in obesity
dependson its roleon thepromotionof adi-
posity, we generatedmice lackingPI3Kg in
the ob/ob background (ob/ob-PI3Kg−/−).
At 9 and 16 weeks of age, ob/ob-PI3Kg−/−
mice had similar body weights as ob/ob
controls and amarginal but significant re-
duction in body lipids (Fig. 1, A and B).
The loss of protection from diet-induced
obesity correlated with the loss of HSL ac-
tivation in this model (Fig. 1, C and D).
Consistent with these findings, adipocyte
size distributionwas similar between ob/ob
andob/ob-PI3Kg−/−mice (Fig. 1E).Between
8 and 9weeks of age, ob/ob-PI3Kg−/−mice
showed improved glucose and insulin toler-
ance (Fig. 1, F and G). However, this im-
provement was smaller than that observed
in the diet-induced obesitymodel (fig. S1, B
andC) andwas largely transient, because by
the age of 15 to 16 weeks, insulin and glu-
cose tolerance were similar in ob/ob and
ob/ob-PI3Kg−/−mice (Fig. 1,Hand I).Anal-
ysis of the areaunder the curveof the glucose
and insulin tolerance tests also confirmed
that loss of PI3Kg in ob/ob mice led to a
partial and transient protection from in-
sulin resistance (Fig. 1J). Liver steatosis,
hepatic proinflammatory gene expression
profile, and expression of genes impli-
cated in lipid handling and metabolism
were similar in livers from ob/ob-PI3Kg−/−
and control ob/ob mice at different time
points (fig. S3,A toF).Macrophage recruit-
ment to crown-like structures and expres-
sion of macrophage markers were similar
in adipose tissue from ob/ob-PI3Kg−/−
mice and that from control ob/ob mice
(Fig. 2, A to E). However, we observed
that loss of PI3Kg shifted gene expression
of macrophages in adipose tissue from
markers of M1 polarization to markers
of M2 activation (Fig. 2, F and G). At the age of 9 weeks, ob/ob-
PI3Kg−/− mice showed reduced adipose tissue expression of some M1
markers (TNFa,MIP-1a, andRANTES) and increased expression of the
M2 marker MMP-9 compared to controls (Fig. 2F). Moreover, in the
adipose tissue from16-week-old ob/ob-PI3Kg−/−mice, the expression of
all the measured M1 markers was similar to controls, but that of M2
markers (Arg-1,MRC-1,MRC-2, andMMP-9) was increased in adipose
tissue from ob/ob-PI3Kg−/− mice (Fig. 2G). Overall, these results indi-
cate that loss of PI3Kg in the ob/obmodel did not significantly affect the
development of adiposity, fatty liver, hepatic inflammation, and, in con-
trast to a previous report (19), the accumulation of adipose tissue
macrophages. However, PI3Kg ablation in ob/ob mice led to a partial
and transient improvement of insulin sensitivity, which correlated with
an adipose tissue gene expression signature indicating a partial M1 to
M2 polarization of adipose tissue macrophages.
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Fig. 1. PI3Kg ablation in ob/ob mice leads to a partial and largely transient protection from insulin resistance
independently from adiposity. (A) Body weight and body composition of 9-week-old ob/ob and ob/ob-PI3Kg−/−mice
kept on standard chow diet. (B) Bodyweight and body composition of 16-week-old ob/ob and ob/ob-PI3Kg−/−mice kept
on standard chow diet. (C) HSL phosphorylation at PKA sites (Ser563 and Ser660) and AMPK site (Ser565) in epididymal
adipose tissue from 16-week-old ob/ob and ob/ob-PI3Kg−/− mice. (D) Quantification of HSL phosphorylation data from
the immunoblots in (C). (E) Adipocyte size distribution of 16-week-old ob/ob and ob/ob-PI3Kg−/−mice in (D). (F) Glucose
tolerance test (GTT) of 8-week-old ob/ob and ob/ob-PI3Kg−/− mice. (G) Insulin tolerance test (ITT) of the mice in (A).
(H) Glucose tolerance test of themice described in (B). (I) Insulin tolerance test of 15-week-old ob/ob and ob/ob-PI3Kg−/−
mice. (J) Area under the curve (AUC) of the glucose and insulin tolerance tests. Data aremeans, SEs are indicated, and P
values are calculated byWilcoxon–Mann-Whitney test and two-way analysis of variance (ANOVA) for glucose tolerance test
and insulin tolerance test curves. (A and B) n = 7 to 9 mice per genotype; (C to E) n = 5mice per genotype; (F to J) n = 9
to 10 mice per genotype.
2
htt
p:/
/do
c.r
ero
.ch
Targeting PI3Kg in lysozyme M–expressing myeloid cells
alters the gene expression profile of obese adipose tissue
To investigate the role of PI3Kg activity in adipose tissue macrophages
during obesity, we generated conditional knockout (KO) mice lacking
PI3Kg in lysozyme M–expressing myeloid cells (PI3KgLysM) by Cre-
LoxP recombination. More specifically, mice with the exons 3 and 4
of Pi3kg flanked by LoxP sites (PI3KgF/F; fig. S4, A and B) were crossed
with mice expressing the cre recombinase under the control of the
lysozyme-M promoter, which is expected to drive a selective cre recom-
bination inmostmyeloid cells. Immunoblot analysis showed that PI3Kg
protein abundance was reduced by about 80% in bonemarrow–derived
macrophages (BMDMs) and by about 50% in total adipose tissue and
adipose tissue stromal vascular fraction of PI3KgLysMmice compared to
PI3KgF/F control mice (fig. S5, A to C). These data indicated that the
efficiency of Pi3kg deletion in adipose tissue myeloid cells of PI3KgLysM
mice was partial. We observed a marginal nonsignificant tendency for
improved insulin tolerance for 12-week-old PI3KgLysM mice (fig. S6B).
However, PI3KgLysM and littermate PI3KgF/F mice showed similar body
weights, insulin sensitivity, and liver histology (fig. S6, A and C to H).
Hepatic expression of lipid-handling genes and phosphorylation of
HSL at the PKA sites in adipose tissue were also similar between
PI3KgF/F and PI3KgLysM mice (fig. S6, I to K). Hepatic expression of M1
and M2 markers was also similar between genotypes, although we ob-
served increased expression of MIP-1a (an M1 cytokine) and ofMRC-2
(anM2marker) in the livers of PI3KgLysMmice (fig. S7A). The number of
crown-like structures and the mRNA abundance of the macrophage
marker F4/80 in adipose tissue were also similar between genotypes
(fig. S7, B to D). However, we observed that the expression of CD68
and CD11C (two markers for adipose tissue macrophages), IL-1Ra
and MIP-1a (two markers of M1 activation), and Arg-1, MRC-1, and
MMP-9 (threemarkers ofM2 activation)was increased in adipose tissues
from PI3KgLysM mice. Overall, these results indicate that during obesity,
PI3Kg activity in lysozymeM–expressingmyeloid cells is dispensable for
macrophage accumulation in adipose tissue but is required for the efficient
polarization of adipose tissue macrophage toward the M1 phenotype.
PI3Kg activity within the hematopoietic-endothelial
compartment promotes insulin resistance and M1 gene
expression in adipose tissue during obesity
Because Pi3kg was partially deleted in adipose tissue myeloid cells from
PI3KgLysMmice (fig. S5A), and because nonmyeloid leukocytes are im-
plicated in promoting classical M1 activation of adipose tissue macro-
phages in obesity (24–26), we generated mice with conditional ablation
of PI3Kg in hematopoietic and endothelial cells (PI3KgHE). PI3KgF/F
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Fig. 2. PI3Kg ablation inob/obmice drives anM2-biased gene expression signature in adipose tissue. (A) Mac-2 staining of epididymal adipose tissue sections from 9- and
16-week-old ob/ob and ob/ob-PI3Kg−/−mice. Scale bars, 100 mm. (B) Quantification of the number of crown-like structures (CLS) in adipose tissue of 9-week-old ob/ob and ob/ob-
PI3Kg−/− mice in (A). (C) Expression of macrophage markers in adipose tissue from 9-week-old ob/ob and ob/ob-PI3Kg−/− mice. (D) Quantification of the number of crown-like
structures in adipose tissue from 16-week-old ob/ob and ob/ob-PI3Kg−/−mice in (A). (E) Expression of macrophage markers in adipose tissue from 16-week-old ob/ob and
ob/ob-PI3Kg−/−mice. (F) Expression ofmarkers forM1- andM2-activatedmacrophages in adipose tissues of 9-week-old ob/ob and ob/ob-PI3Kg−/−mice. (G) Expression ofmarkers
for M1- and M2-activated macrophages in the adipose tissue of 16-week-old ob/ob and ob/ob-PI3Kg−/− mice. Data are means, SEs are indicated, and P values are calculated by
Wilcoxon–Mann-Whitney test. n = 5 mice per group for (A) (16 weeks old) and (D); n = 8 to 13 mice per group for all other data.
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mice were crossed with mice expressing the Cre recombinase under the
control of the Tek (Tie-2) promoter, which drives specific LoxP recom-
bination in endothelial cells and in hematopoietic progenitor cells dur-
ing embryogenesis, and thus in the whole hematopoietic system (27).
PI3KgHE male mice did not show substantial recombination in brain
and liver, and we observed about 30% of recombination in skeletal
muscle, which can at least in part be explained by recombination in en-
dothelial and hematopoietic cells (fig. S8A). We observed about 50% of
genetic recombination in white adipose tissue, more than 80% of re-
combination in adipose tissue stromal-vascular fraction, and essen-
tially a complete recombination in BMDMs, bone marrow, and spleen
(fig. S8A). Immunoblot analysis revealed that PI3Kg was ablated in
BMDMs, reduced by more than 80% in whole white adipose tissue,
and completely ablated in the adipose tissue stromal-vascular fraction
(fig. S8, B and C). Compared to PI3KgF/F mice on a high-fat diet,
PI3KgHE mice on the same diet had similar body weights but showed
improved insulin tolerance and glucose tolerance at the age of 12 to
13 weeks (Fig. 3, A to E). However, this improved insulin sensitivity was
largely transient, because by 21 to 22weeks of age,PI3KgHEmice showed
only a small improvement in insulin tolerance and similar glucose toler-
ance asPI3KgF/F controlmice (Fig. 3, F to J). Steatosis, expression of genes
implicated in lipid handling, HSL phosphorylation, and adipocyte size
distribution were also similar between genotypes (Fig. 3, K to M, and
fig. S9, B and C). We conclude that PI3Kg
activity in the hematopoietic-endothelial
compartments contributes to the develop-
ment of insulin resistance but not to stea-
tosis and adiposity.
Hepatic inflammatory gene expression
was similar betweenPI3KgHE andPI3KgF/F
mice (fig. S9A). The number of crown-
like structures in adipose tissue and the ex-
pression of macrophagemarkers were also
similar between genotypes (Fig. 4, A to E).
However, at the age of 12 weeks, PI3KgHE
mice showed reduced adipose tissue ex-
pression of the gene encoding the M1 cy-
tokine tumor necrosis factor–a (TNFa)
and increased expression of arginase (Fig.
4F). Furthermore, at the age of 23 weeks,
the expression of several genes encoding
M2 markers (Arg-1, MRC-1, MRC-2, and
MMP-9) was significantly increased in
white adipose tissue from PI3KgHE mice
compared to that from PI3KgF/F mice
(Fig. 4G). Thus, PI3Kg activity in hemato-
poietic and endothelial cells is dispensable
for hepatic inflammation and adipose
tissue macrophage recruitment but pro-
motes anM1gene expression profile in ad-
ipose tissue during obesity.
PI3Kg inmacrophages is required for
AKT phosphorylation induced in
response to M1 and M2 activating
signals but plays a minor role in
macrophage polarization
To investigate the cell-autonomous role
of PI3Kg in macrophage activation, we
analyzed AKT phosphorylation in BMDMs from PI3Kg−/− mice and
from wild-type (WT) control mice that were exposed to various
stimuli. Palmitate (PA) treatment did not induce AKT phosphoryl-
ation above basal amounts in BMDMs, which were similar between
macrophages fromWT or PI3Kg−/−mice (fig. S10A). However, PI3Kg
activity in BMDMs was required for efficient AKT phosphorylation
not only in response to LPS and IFNg (interferon-g), two potent acti-
vators of the M1 phenotype, but also in response to IL-4 (interleukin-4)
and IL-13, two potent activators of the M2 phenotype (Fig. 5, A and B).
Next, quantitative polymerase chain reaction (qPCR) analysis of mark-
ers of classical M1 activation and alternative M2 activation was per-
formed on BMDMs from WT and PI3Kg−/− mice that were incubated
with an M1 differentiation medium (LPS + IFNg) or an M2 differen-
tiation medium (IL-4 + IL-13). PI3Kg activity in cultured BMDMs was
not required for M1 activation in response to LPS and IFNg, or for M2
activation in response to IL-4 and IL-13, because PI3Kg−/− BMDMs
showed M1 or M2 gene expression signatures under these experimental
conditions (Fig. 5, C and D). However, we observed several small but
significant differences in gene expression that, with the exception of
MCP-1 in macrophages exposed to the M1 activation medium for
4 hours, orMGL-1 at 24 hours of M1 activation, are consistent with a
role for PI3Kg in promoting macrophage polarization toward classical
M1 activation (Fig. 5, C and D). Overall, our data indicate that PI3Kg
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activity in macrophages is required for AKT signaling in response to
major M1 and M2 polarization signals and plays a modest action in
promoting M1-polarized gene expression.
Loss of PI3Kg activity has a modest effect on signaling
cascades driving M1 and M2 macrophage activation
BMDMs from WT or PI3Kg−/− mice were exposed to various macro-
phage-activating signals to evaluate the role of PI3Kg activity in key
signaling pathways driving classical or alternative macrophage activa-
tion. Loss of PI3Kg did not affect LPS-mediated induction of the kinases
JNK (c-Jun N-terminal kinase) and p38, although we observed a trend
toward decreased IkBa protein abundance in PI3Kg−/− macrophages
after LPS stimulation (Fig. 6A and fig. S10B). However, this trend did
not reach statistical significance, and IkBa protein abundance was simi-
lar betweenWT and PI3Kg−/−macrophages costimulated with LPS and
IFNg (Fig. 6B). Signal transducer and activators of transcription
1 (STAT1) phosphorylation in macrophages exposed to IFNg, or LPS
plus IFNg, and STAT6 phosphorylation in macrophages treated with
IL-4 were not affected by ablation of PI3Kg (Fig. 6, A to C). However,
STAT6 phosphorylation after 2 hours of IL-13 stimulation was signif-
icantly increased in PI3Kg−/− macrophages compared to control WT
macrophages (Fig. 6, C and D). Together, these results challenge the
previously proposed role for PI3Kg in the control of IkBa degradation
in macrophages (14) and indicate that PI3Kg activity in these cells re-
duces STAT6 phosphorylation after prolonged exposure to IL-13.
PI3Kg activity is required for efficient neutrophil recruitment
to adipose tissue
Our data from cultured BMDMs indicated that the M2-polarized gene
expression in adipose tissue of mice lacking PI3Kg was most likely
caused by non–cell-autonomous mechanisms. Because different types
of leukocytes are implicated in adipose tissue macrophage polarization
by controlling the local abundance of IFNg, IL-4, and IL-13, we
measured the concentration of these cytokines in the adipose tissue of
mice lacking PI3Kg. Compared to their controls, ob/ob-PI3Kg−/− and
PI3KgHE mice displayed similar IFNg concentration in adipose tissue,
and IL-13 was slightly increased in adipose tissue from ob/ob-PI3Kg−/−
mice but not in adipose tissue from PI3KgHE mice (fig. S11, A and B).
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Furthermore, adipose tissue abundance of IL-4
was unchanged in ob/ob-PI3Kg−/− mice and
was significantly reduced in PI3KgHE mice
compared to controls (fig. S11, A and B).
Together, these results indicate that PI3Kg
activity in leukocytes does not generally al-
ter adipose tissue abundance of IFNg, IL-4,
and IL-13. Gene expression analysis of endo-
thelial cell activation also indicates that loss of
PI3Kg did not significantly affect activation of
endothelial cells in the obese adipose tissue
(fig. S11, C andD). Adipose tissue neutrophils
have been implicated in obesity-driven M1
polarization of adipose tissue macrophages
by an unknown mechanism that does not in-
volve changes in the local concentrations of
IFNg, IL-4, and IL-13 (28). Because PI3Kg
plays a major role in neutrophil chemotaxis
during acute inflammation (29), we evaluated
the role of PI3Kg in the recruitment of neutro-
phils to adipose tissue. Compared to controls,
ob/ob-PI3Kg−/− andPI3KgHEmice consistently
had fewer adipose tissue neutrophils (defined
as CD11b+Ly6G+ cells) at two different time
points (Fig. 7, A toD). Together, our results in-
dicate that PI3Kg activity in the hematopoietic-
endothelial compartmentdoesnot affect adipose
tissue concentrations of IFNg, IL-4, and IL-13,
or endothelial cell activation, but is required
for efficient recruitment of neutrophils to adi-
pose tissue.
DISCUSSION
Our results clarified the mechanism of action
of PI3Kg in obesity-driven inflammation and
insulin resistance and challenged the current
view on the role of PI3Kg in the control of
macrophage activation and gene expression
(12–14, 30). Our data indicated that PI3Kg
action in metabolic inflammation and insulin
resistance is largely dependent on its role in
the promotion of diet-induced adiposity,
which was correlated with PKA-mediated
phosphorylation of HSL in white adipose
tissue. Nonetheless, our data on PI3Kg abla-
tion in ob/obmice and tissue-specific deletion
of PI3Kg in mice made obese by high-fat diet
feeding indicated that PI3Kg activity in leuko-
cytes contributes to obesity-driven insulin
resistance. The progression of obesity is char-
acterized by polarization of adipose tissue
macrophages from an “M2” tissue remodeling
phenotype (typical of leanmice) toward an in-
flammatory “M1” activation status, characterized
by a switch of the gene expression signature
in the whole adipose tissue (23, 31–34). Here,
we showed that PI3Kg activity in leukocytes
was required for efficient M1-polarized gene
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expression in the adipose tissue of obese mice. These results contrast
with studies reporting that PI3Kg activity in macrophages inhibits
classical macrophage activation and promotes immunosuppressive
gene expression protecting tumors from CD8+ T cell immune re-
sponse (12–15). However, mice lacking a functional PI3Kg display a
markedly impaired antiviral CD8+ T cell response to influenza viral
infection (35), indicating that the role of PI3Kg in CD8+ T cell im-
mune response depends on the specific context. Our observation that
in adipose tissue of obese mice PI3Kg had the opposite effect on mac-
rophage polarization than that described in tumor models indicates
that PI3Kg is not a general inhibitor of classicalmacrophage activation
and that its role inmacrophage polarization is also context-dependent.
In our study, PI3Kg activity in BMDM was required for AKT-1/2
phosphorylation in response to LPS, IFNg, IL-4, and IL-13 but was
dispensable for classical M1 activation of BMDM by LPS and IFNg,
and alternativeM2 activation by IL-4 and IL-13. This observation con-
trasts with studies indicating that PI3Kg is an inhibitor of classical M1
macrophage activation (12–14). However, data from another study
show a nonsignificant trend toward an increased number of M2
macrophages in the atherosclerotic lesions of LDLR−/− mice lacking
PI3Kg (36). Furthermore, the Zotes et al. show that PI3Kg ablation
has no effect on the expression of the M1 markers iNOS (inducible
nitric oxide synthase) and IL-12 and of the M2 markers Arg1, IL-10,
and YM1 in BMDMs stimulated either with LPS and IFNg or with
IL-14 (36). These data are consistent with our results in indicating that
PI3Kg is not a general inhibitor of classical macrophage activation and
that M1- and M2-polarized gene expression can be effectively induced
in macrophages lacking PI3Kg. It is re-
markable that AKT-1 and AKT-2, both
of which required PI3Kg for their activa-
tion by M1 and M2 inducers, play oppo-
site roles in M1 and M2 macrophage
activation, with AKT-1 promoting M2
gene expression and AKT-2 promoting
M1 gene expression (37). Therefore, the
role of PI3Kg in macrophage activation
may depend on the relative abundance
of AKT-1 and AKT-2 within specific
macrophage populations. In our hands,
we observed several small, but signifi-
cant, differences in gene expression in
M1- andM2-polarized BMDMs indicating
that loss of PI3Kg causes a trend toward an
M2 gene expression profile. The action of
PI3Kg in tumor immunosuppression is
proposed to depend on suppression of
PI3Kg activity on IkBa degradation and
nuclear factor kB (NF-kB) activation in
macrophages (14). By contrast, others
propose that NF-kB activity in macro-
phages promotesM2macrophage polariza-
tion andmaintains an immunosuppressing
phenotype in tumor-associatedmacrophages
(38, 39).Weobserved a trend formore ex-
tensive IkBa degradation inBMDMs from
PI3Kg−/−mice exposed to LPS, but this dif-
ference did not achieve statistical signif-
icance, and IkBa protein amounts were
similar in WT and PI3Kg−/− BMDM co-
stimulated with LPS and IFNg. Finally, the expression of several
NF-kB–regulated genes (TNFa, IL-6, IL-1b, MIP-1a, IL-1Ra, and
RANTES) was either not affected or slightly reduced by loss of PI3Kg in
activated BMDMs, indicating that PI3Kg is not an essential inhibitor of
NF-kB in macrophages. Among the signaling pathways that we have
investigated in BMDMs, the only statistically significant difference that
we observed was increased STAT6 phosphorylation after 2 hours of
IL-13 stimulation. A similar trend was observed for IL-4–stimulated
macrophages, although it did not reach statistical significance. This pro-
longed STAT6phosphorylationmay explain the small trend towardM2
gene expression that we observed in PI3Kg−/− BMDMs exposed to M1
or M2 activation medium, which, however, is much smaller than the
effect observed in vivo in adipose tissue. Overall, we conclude that
PI3Kg controls macrophage gene expression by a mechanism that is
not entirely cell-autonomous and that can lead to opposite outcomes
in polarized gene expression in macrophages depending on the specific
context. Several types of leukocytes are implicated in M1 polarization
of adipose tissue macrophages in obesity by modulating the local
abundance of IFNg, IL-4, and IL-13 (40). In our experimental settings,
macrophage polarization was not explained by local changes in these
cytokines, but we observed that loss of PI3Kg consistently reduced ad-
ipose tissue neutrophil number. Neutrophils, which are not a relevant
source of IFNg, IL-4, or IL-13, promotemacrophageM1 polarization in
the adipose tissue of obese mice (28). Hence, PI3Kg may promote ad-
ipose tissue macrophage inflammatory gene expression at least in part
through its action on adipose tissue neutrophil accumulation,most like-
ly due to PI3Kg activity in neutrophil chemotaxis (Fig. 7E). In contrast
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to macrophages, neutrophils are short-lived cells with a high turnover
rate that do not proliferate and that rely on PI3Kg-dependent chemo-
taxis to maintain their population at the site of inflammation (29). In
our study, we observed a good correlation
between TNFa mRNA abundance in adi-
pose tissue and glucose intolerance; thus, it
is possible that the transient protection ob-
served in ob/ob-PI3Kg−/− and PI3KgHE
mice depends on reduced TNFa expres-
sion. TNFa plays amajor role in the devel-
opment of insulin resistance in ob/obmice
and in mice on a high-fat diet (41).
Together, three major conclusions can
be drawn from our study. First, the action
of PI3Kg in obesity-driven inflammation
and insulin resistance depends largely on
its role on adiposity, which is mediated
by PI3Kg activity in a cell type outside
the hematopoietic-endothelial compart-
ment, and requires functional leptin sig-
naling. Second, PI3Kg activity in leukocytes
is required for efficient polarization of in-
flammatory gene expression and neutro-
phil accumulation in adipose tissue (Fig.
7E), which promotes an early onset of in-
sulin resistance.Our third and final conclu-
sion is that PI3Kg action in macrophage
activation is not cell-autonomous and is
context-dependent. Hence, the outcome
of pharmacological strategies aiming at tar-
geting PI3Kg in macrophages is not easily
predictable because it may lead to opposite
effects depending on the specific immune
context.However,we expect that PI3Kg in-
hibition in leukocytes will delay the devel-
opment of insulin resistance in obesity,
providing an additional metabolic protec-
tion on top of the potent antiobesogenic
effects of PI3Kg inhibition.
MATERIALS AND METHODS
In vivo studies
All mice were males on C57BL/6 genetic
background and were kept at our standard
facility (two to five per cage at 22°C under
12-hour light/12-hour dark cycles). Mice
wereweaned at 4weeks of age on chowdiet
and, for the diet-induced obesity model,
were placed on a high-fat diet, 60% of
calories from fat from Bio-Serv (diet F3282),
between5and6weeksof age. Littermate con-
trols were used for mice with tissue-specific
ablation of PI3Kg. Animal experiments were
approved by the cantonal veterinary commit-
tee and by the Ethics Committee on Ani-
mal Care andUse inGothenburg, Sweden.
PI3Kg−/− mice were previously described
(18), and ob/ob-PI3Kg−/− mice were ob-
tained by crossing PI3Kg−/− mice with ob/+ mice. PI3KgF/F mice were
obtained by crossing Pik3cg<tm1a(EUCOMM)Wtsi>/Wtsi mice [from
the European Conditional Mouse Mutagenesis Program (EUCOMM)]
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Wilcoxon–Mann-Whitney test. (E) A model describing the effects of PI3Kg activity in leukocytes in obesity-driven adipose
tissue inflammation. In WT mice, the transition from lean to obese is characterized by leukocyte infiltration of adipose
tissue and macrophage polarization toward an M1 phenotype. Mice lacking PI3Kg in their leukocytes display reduced
accumulation of adipose tissue neutrophils and reduced M1 polarization of adipose tissue gene expression, which is
correlated with a delayed onset of insulin resistance.
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with mice expressing the Flippase (FLP) recombinase under the consti-
tutive actin promoter (fig. S4). PI3KgLysM and PI3KgHE mice were gen-
erated by crossingPI3KgF/Fmicewith transgenicmice (from the Jackson
Laboratory) expressing the Cre recombinase under the control of the
lysozyme-M promoter (for PI3KgLysM) or the TEK (Tie2) promoter
(for PI3KgHE mice). Body composition was determined by soxhlet ex-
traction, and adipocyte distribution size was performed by image anal-
ysis of tissue sections as previously described (18). For glucose tolerance
and insulin tolerance, mice were fasted for 6 hours and were injected
intraperitoneally with a glucose bolus of 1 g/kg body weight (for glucose
tolerance test), orwith 1 iU insulin/kg (for insulin tolerance test). Tissues
were collected from mice in the fed state.
Cell culture studies
BMDMs were prepared from bone marrow cells from either WT or
PI3Kg−/− mice. Cells were differentiated in macrophages in vitro by
culturing bone marrow cells in RPMI with L-glutamine supplemented
with 10% fetal calf serum, 1% penicillin/streptomycin, and 1/10 volume
of L929 cell–conditioned medium for 6 days. For signal transduction
studies, BMDMs were serum-starved for 2 hours and stimulated with
LPS (100 ng), IFNg (150 ng), IL-13 (150 ng), or IL-4 (150 ng) for the
indicated times. For in vitro differentiation into M1- or M2-activated
macrophages, BMDMs were cultured for 4 or 24 hours with RPMI in
the presence of either 10-ng LPS and 10-ng IFNg (forM1) or 10-ng IL-4
and 10-ng of IL-13 (for M2).
Molecular analysis
Total RNA was isolated from tissues by the guanidinium thiocyanate
extraction method. complementary DNA was prepared using a re-
verse transcription kit (Promega), and qPCR was performed using a
commercial SYBR green mix using specific primers (table S1). For im-
munoblot analysis, PI3Kg antibodies were previously described (42);
other commercial antibodies were antibodies against tubulin (Sigma),
total AKT and AKT Ser473, total HSL, and phospho-specific anti-
bodies for serines 563, 660, and 595 of HSL (Cell Signaling). Adipose
tissue crown-like structure staining and quantification were per-
formed as described (18). Adipose tissue neutrophils were quantified
by immunostaining of paraffin-embedded adipose tissue sections.
Antigen retrieval was performed using Dako solution (Dako).
Sections were blocked with 5% bovine serum albumin in phosphate-
buffered saline (PBS) 1 hour at room temperature and stained with
Ly6g (1:50, 1A8, BD Bioscience) and CD11b (1:50, Abcam) over-
night at 4°C in blocking solution. Slides were washed in PBS and
incubated for 1 hour at room temperature with Alexa Fluor 488/
594–conjugated antibody (1:200, Life Technologies). Adipose tissue
neutrophils are defined as CD11b+Ly6g+ cells. Cell nuclei were
stained with 4′,6-diamidino-2-phenylindole, images were acquired
by fluorescence microscopy (Zeiss), and neutrophils were counted
in five random fields per section.
Statistical analysis
Data are means, and error bars indicate SEs. P values were calculated,
as indicated in the figure legends, by eitherWilcoxon–Mann-Whitney
test or Student’s t test for simple comparison and by two-wayANOVA
followed by Sidak when two different categorical variables are
considered (such as for the glucose tolerance test and insulin tolerance
test curves). Data were visually inspected by box plot before applying
parametric methods. P < 0.05 is considered statistically significant.
Statistical analysis was performed with the GraphPad Prism software.
SUPPLEMENTARY MATERIALS
www.sciencesignaling.org/cgi/content/full/10/488/eaaf2969/DC1
Fig. S1. Protection from diet-induced obesity and insulin resistance, altered expression of lipid-
handling genes, and increased HSL phosphorylation in PI3Kg−/− mice.
Fig. S2. Obesity-driven inflammation is markedly decreased in PI3Kg−/− mice on a high-fat diet.
Fig. S3. PI3Kg ablation in ob/obmice does not significantly affect the development of fatty liver
and hepatic gene expression.
Fig. S4. Schematic representation of the targeted Pi3kg allele.
Fig. S5. Deletion efficiency of PI3Kg in PI3KgLysM mice.
Fig. S6. Lysozyme-M-CRE–mediated targeting of PI3Kg in myeloid cells does not protect from
diet-induced obesity and insulin resistance.
Fig. S7. Lysozyme-M-CRE–mediated PI3Kg gene deletion alters the expression of markers of
macrophage activation in the adipose tissue of mice with diet-induced obesity.
Fig. S8. Deletion efficiency and specificity of PI3Kg in PI3KgHE mice.
Fig. S9. PI3Kg ablation in hematopoietic and endothelial cells does not affect hepatic
inflammatory gene expression profile, steatosis, and expression of lipid metabolism genes.
Fig. S10. Effects of PA on AKT phosphorylation and effects of LPS on IkBa degradation in WT
and PI3Kg−/− BMDMs.
Fig. S11. Loss of PI3Kg in leukocytes does not increase IFNg, IL-4, or IL-13 protein abundance or
endothelial cell activation in adipose tissue of obese mice.
Table S1. List of primers used for real-time qPCR.
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